South African researchers keep wary eye on yet another new coronavirus variant


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
New Covid variant detected in SA

Genetics researchers who have been watching for new coronavirus variants say they've seen a troubling new lineage that carries many of the same hallmarks as other strains, including Alpha, Beta and Gamma.

The variant they are watching, called C.1.2, has popped up across South Africa as well as in seven other countries in Africa, Asia and the Pacific, the researchers report. They're not sure whether its constellation of mutations will make it more dangerous, but it carries changes that have given other variants increased transmissibility and the ability to evade the immune system's response to some degree.


Having more mutations does not necessarily equal more danger -- some mutations can weaken a virus and it's the combination of changes that affects whether a virus becomes more efficient. One extra mutation could cancel out the effects of another.
But the team -- which includes virologist Penny Moore of South Africa's National Institute for Communicable Diseases -- say they are keeping an eye on it.
"We are currently assessing the impact of this variant on antibody neutralization following SARS-CoV-2 infection or vaccination against SARS-CoV-2 in South Africa," they wrote in a report posted online as a preprint.

"This variant has been detected throughout the third wave of infections in South Africa from May 2021 onwards and has been detected in seven other countries within Europe, Asia, Africa and Oceania. The identification of novel SARS-CoV-2 variants is commonly associated with new waves of infection."

It's too soon for the variant to be designated a variant of interest or a variant of concern by the World Health Organization, so it does not yet have a Greek alphabet designation. WHO currently names four variants of concern, which are more easily transmitted, affect severity of disease or evade tests, vaccines or treatments: Alpha or B.1.1.7; Beta or B.1.351; Gamma or P.1; and Delta or B.1.617.2. Variants of interest, which have troubling mutations and have caused clusters of illness, include Eta or B.1.525; Iota or B.1.526; Kappa or B.1.617.1 and Lambda or C.37, according to WHO.

Maria van Kerkhove, technical lead on Covid-19 for WHO, noted that very few people diagnosed with coronavirus have been found to be infected with the C.1.2 variant.

"To date there are around 100 sequences of C.1.2 reported globally, the earliest reports from May '21 from South Africa," she said on Twitter.

"At this time, C.1.2 does not appear to be rising in circulation," she added. She said WHO would update people on its website and via news conference if that changes.

Monitoring & assessment of variants is ongoing & critically important to understand the evolution of this virus, in fighting COVID-19 & adapting strategies as needed," she added. So far, the Delta variant is still dominant, Van Kerkhove said.

Some variants, such as Alpha and Delta, have quickly spread to become the dominant variants in much of the world. Others have spread more regionally, including Beta and Gamma. Others have looked troubling but caused only sporadic outbreaks.

Tags : #SouthAfrica #CoronavirusVariant #DeltaVariant #NationalInstituteForCommunicableDiseases

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026